Natco Pharma Limited — Others, 08-01-2025: Action(s) initiated or orders passed

NATCO Pharma Limited has received an order from the Assistant Commissioner of Central Goods & Services Tax Division, Dehradun, imposing a penalty of ₹38.36 crore due to disallowed input tax credit related to inadmissible Transitional Credit under GST. The company plans to appeal this decision. Importantly, the management stated that this order does not have a material impact on its financial or operational activities. Investors may view this as a neutral impact, with minimal risk to the company's financial health, but the pending appeal could introduce some variability in future assessments.